Clinical Trial Update: Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing equivalence of generic pimecrolimus cream 1% to Elidel 1% in mild to moderate atopic dermatitis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Elidel (pimecrolimus)
• Pimecrolimus Cream 1% (pimecrolimus)

Snippet

Sponsor: Actavis Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2020-04-24